Abstract
Clozapine, an atypical neuroleptic, does not cause extrapyramidal symptoms of Parkinsonism and dystonia and appears to have a reduced or absent capacity to produce tardive dyskinesia. 37 subjects, most with chronic schizophrenia, were treated with clozapine and TD outcome was analyzed. A subset of these subjects underwent plasma and CSF studies. TD response was heterogenous, but a proportion of patients improved with clozapine treatment. Neurochemical data differed from published reports of classical neuroleptics with the most robust effect produced by clozapine seen in CSF norepinephrine levels. Other neurochemical data and implications for the mechanism of clozapine in TD are reviewed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burki HR, Ruch W, Asper H, Baggiolini M, Stille G (1974) Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur J Pharmacol 27:180–190
Cohen DJ, Shaywitz BA, Johnson WT, Bowers M (1974) Biogenic amines in autistic and atypical children. Arch Gen Psychiatry 31:845–853
Cole JO, Gardos G, Tarsy D, Granacher RP, Sniffin C, Vanderkolk B, Trenholm I (1980) Drug trials in persistent dyskinesia. In: Fann WE, Smith RC, Davis JM, Domino EF (eds) Tardive dyskinesia, research and treatment. SP Medical and Scientific Books, New York, pp 419–427
Friedman RL, Sanders-Bush E, Barrett RL (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106:191–193
Gattaz WF, Waldmeier P, Beckmann H (1982) CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand 66:350–360
Gerbino L, Shopsin B, Collora M (1980) Clozapine in the treatment of tardive dyskinesia: an interim report. In: Fann WE, Smith RC, Davis JM, Domino EF (eds) Tardive dyskinesia, research and treatment. SP Medical and Scientific Books, New York, pp 475–489
Iadarola MJ, Berman KF, Karp BP, Suddath R, Mouradian MM, Lieberman J, Kane JM (1989) Cerebrospinal fluid met5-enkephalin-arg6-gly7-leu8 immunoreactive peptides: differential effect of haloperidol compared to clozapine. Schizophrenia Res 2:152
Jeste DV, Lohr JB, Kaufmann CA, Wyatt RJ (1986) Pathophysiology of tardive dyskinesia; evaluation of supersensitivity theory and alternative hypotheses. In: Casey DE, Gardos G (eds) Tardive dyskinesia and neuroleptics: from dogma to reason. American Psychiatric Press, Washington DC, pp 15–32
Kane J, Honigfeld G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine. Arch Gen Psychiatry 45:789–796
Kendler KS, Mohs RC, Davis KL (1983) The effects of diet and physical activity on plasma homovanillac acid in normal human subjects. Psychiatr Res 8:215–223
Lieberman J, Kane J, Woerner M, Weinhold P, Basavaraja N, Kurucz J, Bergmann K (1984) Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 20:382–386
Lieberman J, Kane J, Johns C, Vital-Herne J (1986) Clozapine: clinical evidence of novel effects. Clin Neuropharmacol 9:140–141
Lieberman J, Johns C, Pisciotta A, Kane J, Cooper T (1988) Neurochemical and immunologic effects of clozapine in chronic schizophrenia. Presented at the American College of Neuropsychopharmacology 27th Annual Meeting, December 11–16, 1988, San Juan, Puerto Rico
Lieberman JA, Saltz BL, Johns CA, Pollack S, Kane J (1989) Clozapine effects on tardive dyskinesia. Psychopharmacol Bull (in press)
Richardson M, Suckow R, Whittaker R, Perumal A, Boggiano W, Szirak I, Kushner H (1988) Phenylalanine, phenylethylamine and tardive dyskinesia in psychiatric patients. In: Boulton AA, Jerio AV, Downer R (eds) Trace amines: comparative and clinical neurobiology. Humana Press, pp 409–422
Schmutz J, Eichenberger E (1982) Clozapine. Chronicles of drug discovery 1:39–59
Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand [Suppl] 212:11–19
van Kammen DP, Peters J, van Kammen WB (1986) Cerebrospinal fluid studies of monoamine metabolism in schizophrenia. Psychiatr Clin N Am 9:81–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lieberman, J., Johns, C., Cooper, T. et al. Clozapine pharmacology and tardive dyskinesia. Psychopharmacology 99 (Suppl 1), S54–S59 (1989). https://doi.org/10.1007/BF00442560
Issue Date:
DOI: https://doi.org/10.1007/BF00442560